PRIMARY STUDY
Cannabis use as a factor of lower corpulence in hepatitis C-infected patients: results from the ANRS CO22 Hepather cohort
Key Findings: In this long-term cohort study of patients with chronic hepatitis-C infection (HCV) one of the key findings was that cannabis use was associated with less likelihood of central obesity, obesity, and being overweight than non-cannabis users.
Type of Study: Meta-analysis
Study Sample Size: 10667
Study Result: Positive
Research Location(s): France
Year of Pub: 2022
Cannabinoids Studied: Cannabidiol (CBD), Tetrahydrocannabinol (THC), Cannabinoid (unspecified), Endocannabinoid (unspecified), Tetrahydrocannabivarin (THCV)
Phytocannabinoid Source: Unspecified
Receptors Studied: CB1, CB2, GPCR 55, TRPs, PPARs
Citation: Barré T, et al. Cannabis use as a factor of lower corpulence in hepatitis C-infected patients: results from the ANRS CO22 Hepather cohort. J Cannabis Res. 2022; 4:31. doi: 10.1186/s42238-022-00138-9
Authors: Barré T, Carrat F, Ramier C, Fontaine H, Di Beo V, Bureau M, Dorival C, Larrey D, Delarocque-Astagneau E, Mathurin P, Marcellin F, Petrov-Sanchez V, Cagnot C, Carrieri P, Pol S, Protopopescu C, ANRS/AFEF Hepather study group
